Dario Altieri

Title: The Innovations of Dario Altieri

Introduction

Dario Altieri, based in Philadelphia, PA, is a distinguished inventor known for his groundbreaking work in the field of cancer research. With a focus on innovative therapeutic strategies, he has developed a significant patent that aims to advance treatment options for malignancies, particularly myeloma.

Latest Patents

Dario Altieri holds a patent for a variant survivin vaccine designed for the treatment of myeloma. This invention encompasses a double mutant form of the survivin polypeptide, along with nucleic acid molecules that encode this variant. The patent details various applications, including the use of antigen presenting cells (APCs) like dendritic cells to induce immune responses or treat malignancies using the unique survivin polypeptide.

Career Highlights

Throughout his career, Dario has made notable contributions to cancer research. He has worked with reputable institutions, including the H. Lee Moffitt Cancer Center and Research Institute, and The Wistar Institute of Anatomy & Biology. His dedication to advancing medical science has significantly impacted the field.

Collaborations

Dario's innovative work often involves collaboration with other esteemed researchers, including Frederick L. Locke. These partnerships have fostered a collaborative environment aimed at enhancing the understanding and treatment of complex diseases.

Conclusion

Dario Altieri exemplifies the spirit of innovation in the medical research domain. His patented survivin vaccine represents a promising advancement in the fight against myeloma, showcasing the vital role inventors play in developing new therapeutic options. As research continues, his contributions will undoubtedly help shape the future of cancer treatment.